FDA To Allow Marketing For Bleeding Skull Detection Tool

Posted on

According to news sources, the Food and Drug Administration has just given approval to InfraScan Inc. of Philadelphia to begin marketing the first non invasive hand-held device to be utilized in detecting bleeding skulls.

The device, named the Infrascanner Model 1000, uses near-infrared spectroscopy to help identify bleeding in the skull. Health care providers will be able to utilize the device to extract crucial information about the patient. In conjunction with other clinical information, the healthcare provider can then determine the need for further diagnostics, by using for example a CT scan.

The device utilizes a certain wavelength of light that is capable of penetrating both bone and tissue and transmit the crucial information to a handheld computer.

An FDA review found that the device was able to detect up to 75 percent of hematomas cases that CT scans detected.

As a personal injury lawyer Los Angeles, I appreciate all efforts made to ensure higher safety standards to protect those injured in collisions and accidents on the roadway. The conclusions of this innovative endeavor seem to suggest that the detection time of bleeding skulls will be shortened in some cases by utilizing this device. As a Los Angeles personal injury attorney, I hope that supplying this information will help people stay safe.